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Mitigating the effect of persistent postnatal depression on 
child outcomes through an intervention to treat depression 
and improve parenting: a randomised controlled trial
Alan Stein, Elena Netsi, Peter J Lawrence, Charlotte Granger, Claire Kempton, Michelle G Craske, Alecia Nickless, Jill Mollison, D Anne Stewart, 
Elizabeth Rapa, Valerie West, Gaia Scerif, Peter J Cooper*, Lynne Murray*
Summary
Background Maternal postnatal depression occurs following 10–15% of births and is associated with a range of 
negative child outcomes. Risks to children are particularly increased when postnatal depression is persistent. 
We aimed to examine whether a parenting video-feedback therapy (VFT) intervention versus a control treatment of 
progressive muscle relaxation (PMR), both added to cognitive behavioural therapy (CBT) for persistent postnatal 
depression, would lead to improved child outcomes at age 2 years.
Methods In this two-arm, parallel-design, individually randomised controlled trial, we recruited a community sample 
of women aged 18 years or older living within 50 miles of Oxford, UK, between 4·5 and 9·0 months post partum. All 
participants met diagnostic criteria for current major depressive disorder that had persisted for at least 3 months and 
had infants at 35 or more weeks of gestation, with a birthweight of 2000 g or greater, and without serious neonatal 
complications. Through a centralised service, women were randomly assigned by use of a minimisation algorithm, to 
receive either VFT or PMR, balanced for child sex, temperament, age, socioeconomic status, and severity of 
depression. Both groups also received CBT for depression. Primary outcomes were child cognitive development, 
language development, behaviour problems, and attachment security at age 2 years. There were 11 home-based 
treatment sessions before child age 1 year, followed by two booster sessions in the second year. Assessors were masked 
to treatment group allocation. All analyses were done according to the intention-to-treat principle. This trial is 
registered with the ISRCTN registry, number ISRCTN07336477.
Findings Between March 18, 2011, and Dec 9, 2013, we randomly assigned 144 women, 72 to each group. Primary 
outcome data were available for 62–64 (86–89%) VFT and 67–68 (93–94%) PMR participants. There were no group 
differences in child outcome (cognitive development, adjusted difference –1·01 [95% CI –5·11 to 3·09], p=0·63; 
language development, 1·33 [–4·16 to 6·82], p=0·63; behaviour problems, –1·77 [–4·39 to 0·85], p=0·19; attachment 
security, 0·02 [–0·06 to 0·10], p=0·58), with both groups achieving scores similar to non-clinical norms on all 
outcomes. There were six serious adverse events: five in the VFT group (in two participants) and one in the PMR 
group. None was treatment-related.
Interpretation The effect of persistent postnatal depression on children is a major public health issue. For both 
treatment groups there was sustained remission from depression, and child development outcomes were in the 
normal range. The precise mechanisms accounting for the observed positive child outcomes cannot be ascertained 
from this study.
Funding Wellcome Trust.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. 
Introduction
Maternal postnatal depression affects 10–15% of women 
in high-income countries,1 with substantially higher rates 
in low-income and middle-income countries. Symptoms 
of postnatal depression are the same as those for 
depression in other contexts and significantly affect 
functioning. Indeed, suicide, which commonly has its 
origins in depression, is the second most frequent cause 
of maternal mortality in high-income countries.2
Postnatal depression can have wide-ranging negative 
effects on child development. In early childhood, these 
effects include impairments in cognitive performance, 
behaviour disturbance, and insecurity of attachment; 
these problems can persist into late childhood and 
adolescence.3,4 The economic costs associated with 
the effects of perinatal mental disorders on child 
development are substantial—estimated at £8·1 billion 
per year in the UK alone.5
The negative effects of postnatal depression on child 
development are particularly marked when the 
depression persists beyond the first few months post 
partum6,7 and when the mood disturbance tends to be 
severe. Yet, treatment trials aiming to improve maternal 
and child outcomes have rarely targeted such prolonged 
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postnatal depression. Instead, they have typically 
evaluated relatively brief interventions delivered in the 
early postnatal months. These interventions have not 
shown long-term benefits in either maternal mood or 
child outcomes.8–11 There is, therefore, a need to evaluate 
interventions that target more persistent forms of 
postnatal depression.
The possibility that child outcomes will improve with 
more intensive interventions derives from studies of 
depressed parents of older children, where remission of 
parental depression was associated with marked 
improvements in child outcomes.12–14 However, it is not 
known whether this observation also holds true for 
children in their first 2 years of life, when they are 
maximally dependent on their parents and the 
foundations of key developmental achievements are laid.
There is substantial evidence that parenting difficulties 
mediate, at least in part, the negative effect of postnatal 
depression on child development,15,16 with low maternal 
contingent responsiveness leading to poor cognitive 
development,3,4 low sensitivity leading to insecure 
attachment,7 and poor support for infant emotion 
regulation leading to child behaviour problems.3 These 
observations have led to the view that treatments for 
postnatal depression might require a specific parenting 
component to benefit child outcomes.17,18 Indeed, some 
studies have reported that interventions designed 
specifically to enhance the mother–infant relationship in 
the context of postnatal depression benefit the 
mother–child relationship and reduce the negative effect 
of maternal depression on child outcomes when 
measured in the shorter term.19,20 However, these studies 
have been limited by comparisons with controls involving 
either no or minimal treatment and by small sample 
sizes. Furthermore, the scant evidence available on child 
outcomes beyond late infancy has been negative.9,10,21
An important unaddressed question is whether a 
specific parenting intervention improves child outcomes 
when compared with an intervention not focused on 
parenting, in a setting where both groups also receive 
treatment for persistent postnatal depression.
We therefore did a randomised controlled trial in which 
all participants received intensive treatment for persistent 
postnatal depression, and investigated whether an 
additional specific parenting intervention would be more 
effective in preventing adverse outcomes in children 
than an additional control intervention not focused 
specifically on parenting.
The specific intervention to address the mother–infant 
relationship was video-feedback therapy (VFT),22 an 
intervention shown to be effective in a range of 
contexts.19,22 The aim of the intervention was to target 
Research in context
Evidence before this study
Postnatal depression has long-term adverse effects on child 
development, with risks being particularly increased for 
children exposed to persistent postnatal depression. Since 
parenting is a mediator of the association between postnatal 
depression and child outcomes, a specific intervention 
component might be required to address parenting in the 
context of treating maternal depression. We searched 
MEDLINE, PsycINFO, and the Cochrane library using search 
terms for maternal depression, randomised controlled trial, or 
treatment and child outcomes (for full details of search terms 
see the appendix) from inception to Dec 8, 2017. We identified 
ten relevant reviews and 34 randomised controlled trials or 
quasi-experimental studies that examined the effects of 
interventions for women with postnatal depression on 
parenting or child development, or both. Overall, results 
suggest that treatment of the depression alone might not be 
sufficient to significantly benefit child outcomes. No 
randomised controlled trial to date has examined whether 
a parenting intervention, added to a standardised 
evidence-based treatment for depression, improves child 
outcomes.
Added value of this study
This randomised controlled trial sought to address a gap in the 
literature for women with persistent postnatal depression. We 
examined whether video-feedback therapy (VFT), when 
compared with progressive muscle relaxation (PMR; the control 
treatment), led to improved cognitive, language, behaviour, 
and attachment outcomes in children of women receiving 
cognitive behavioural therapy (CBT) for postnatal depression. 
At child age of 2 years we found no significant differences 
between VFT and PMR, with child development outcomes for 
both groups of children being similar to the norms for 
non-clinical populations. Levels of maternal depression fell 
markedly across both groups by the end of treatment (at 1 year) 
and improvements were sustained at 2 years. Most children 
were therefore not exposed to significant maternal depression 
from the latter part of their first year through to the entire 
second year of life, suggesting that treating the mother’s 
depression effectively and maintaining remission could 
mitigate longer-term negative effects of persistent postnatal 
depression on the child.
Implications of all the available evidence
Since the risk of negative child outcomes is particularly elevated 
in the context of persistent and severe maternal depression, and 
since brief interventions for postnatal depression are unlikely to 
lead to long-term maternal remission and improved child 
development, effective treatments for mothers are crucial in this 
context. Treatments are more likely to be effective when intensive 
and extended by boosters, and are likely to be particularly 
acceptable when delivered in mothers’ homes. Such treatments 
have substantial implementation costs, but in the long term they 
are likely to yield important benefits to both maternal mental 
health and child development, and will reduce costs to society.
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those parenting behaviours affected by postnatal 
depression that are associated with adverse child 
outcomes.3,4 We used an active control treatment, 
progressive muscle relaxation (PMR), which is commonly 
used for stress management,23 but which does not target 
parenting practices or the mother–child interaction. The 
intervention for treatment of maternal depression, 
provided to all participants, was cognitive behavioural 
therapy (CBT)24 with a principal focus on behavioural 
activation, a form of treatment that produces robust 
effects on depression.25
We aimed to address whether, in the context of 
providing CBT for persistent postnatal depression, a 
parenting intervention (VFT) would lead to better child 
cognitive, language, behavioural, and attachment 
outcomes than a control treatment (PMR) at age 2 years.
Methods
Study design and participants
We did a two-arm, community-based, parallel group, 
individually randomised controlled trial. Mothers were 
recruited from the Oxfordshire, Buckinghamshire, and 
Berkshire counties in the UK via general practitioners 
(GPs), health visitors, and other psychological services, 
and from posters and leaflets displayed in primary care 
facilities and Children’s Centres. GPs and health visitors 
gave an overview of the study to potential participants 
and provided a leaflet and contact information. Mothers 
could telephone or email the study team, or return 
self-referral forms in the post. Mothers needed to contact 
the study team directly rather than be referred by a 
health-care professional. In some instances, a health 
visitor or GP contacted the team on the mother’s behalf, 
following discussion with the mother. A member of the 
study team would then contact the mother to assess her 
eligibility for the study based on the inclusion and 
exclusion criteria. Women were included if they met full 
diagnostic criteria for current major depressive disorder 
and had been depressed for at least the previous 3 months 
or the first postnatal 3 months  (in fact, all women met 
criteria for persistent depression in the previous 
3 months), were 18 years or older, and if their infants 
were born at 35 or more weeks of gestation, with a 
birthweight of 2000 g or greater, were aged 
4·5–9·0 months, and had no serious medical 
complications. Women were excluded if they were unable 
to converse in English, had another severe psychiatric 
diagnosis or serious physical illness, were not cohabiting 
with the child, or were receiving psychological therapy. 
Women on antidepressant medication were not excluded. 
Recruitment began in March 18, 2011, and ended in 
Dec  9, 2013. Following an initial telephone screen, a 
home visit was arranged for full assessment. All 
participants provided written informed consent. The 
study received approval from the local National Health 
Service (NHS) research ethics committee (10/H0505/55). 
The study protocol is available online. 
Randomisation and masking
After eligibility was established, consent agreed, and 
baseline data collected, participants were allocated to the 
VFT or PMR treatment group through a centralised 
randomisation service provided through the Oxford 
Cognitive Health and Neuroscience Clinical Trials Unit. 
A random-deterministic minimisation algorithm was 
used to produce treatment groups balanced for child sex 
(male or female), socioeconomic status of the mother or 
of the highest earner in the household if the mother was 
unemployed (defined as non-manual or manual and 
categorised according to the Office for National Statistics, 
Standard Occupational Classification 2010, vol 2), infant 
temperament (not difficult or difficult), severity of 
postnatal depression (moderately severe or severe on the 
Structured Clinical Interview for DSM-IV Clinical 
Severity Rating [SCID-CSR] scale), and age of child 
(<7 months or ≥7 months). Randomisation was done by 
the trial coordinator. Assessors were masked to treatment 
allocation.
Procedures
All participants received CBT plus one of the two other 
interventions: VFT or PMR. Each participant received 
therapy from a single therapist, with each session lasting 
approximately 1·5 h. The first session was CBT, the 
second was either VFT or PMR, and all subsequent 
sessions were equally divided between CBT and either 
VFT or PMR (45 min each). Six weekly sessions were 
followed by five fortnightly sessions, and two booster 
sessions between 6 months and 10 months after the end 
of therapy. Therapists were allocated participants from 
both groups to maintain a balance between VFT and 
PMR. Therapy adherence was facilitated by face-to-face 
weekly 90-min supervision (by AS, LM, PJC, and DAS), 
and Skype supervision calls (by MGC). Therapists 
brought audio-recorded excerpts to supervisions, and 
video recordings for VFT. All sessions were delivered in 
mothers’ homes (or, rarely, at a mother’s request, an 
alternative location such as a Children’s Centre).
VFT aimed to improve the quality of the mother–child 
interaction by enhancing three core parenting skills: 
maternal attention to infant cues and associated 
contingent responsiveness; emotional scaffolding 
(largely comprising warmth and support); and sensitivity 
and treating the child as a psychological agent, 
particularly in the context of attachment needs. 
Additional details of the therapy are provided in the 
appendix.
PMR involved exercises in tensing and relaxing major 
muscle groups combined with attention to sensations26 
(see appendix). Participants were given an audio 
recording of 16 pre-recorded tracks comprising the 
guided relaxation exercise to enable practice between 
sessions.
CBT targeted symptoms of depression by use of 
cognitive and behavioural activation techniques. 
For the study protocol see 
https://www.psych.ox.ac.uk/
research/cap/recent-studies/opt-
study
Articles
www.thelancet.com/psychiatry   Vol 5   February 2018 137
See Online for appendix
Behavioural activation has been shown to be particularly 
effective in the treatment of depression25 and this aspect 
of the CBT model24 was the principal focus of the 
intervention. We focused on behavioural activation 
because this approach allowed us to direct our therapeutic 
efforts to features common in postnatal depression, 
including withdrawal from rewarding activities and an 
absence of routine or structure. For example, the 
intervention was adapted to the management of sleep 
routines, self-care activities, and support networks. The 
intervention included cognitive techniques in the latter 
sessions. Additional details are provided in the appendix.
The four therapists who delivered the interventions 
were qualified clinical psychologists, all with specialist 
CBT training. VFT training included a 1-week course 
provided by developers of VFT22 (to three of the therapists, 
with the fourth, who joined the team later, trained by the 
principal investigators) and additional 2-day training 
provided by AS, LM, and PJC. PMR training was provided 
by MGC over 2 days. Behavioural activation training was 
provided by Heather O’Mahen over 1 day. Training in 
CBT (behavioural activation plus cognitive techniques) 
and PMR was finalised over 4 days by AS, MGC, and 
DAS.
All therapy sessions were digitally audio-recorded and 
written records made. Adherence to treatments was 
assessed by independent masked raters. Good levels of 
fidelity to each treatment were found (appendix).
Maternal perceptions of the treatment questionnaire 
were included to ensure treatments were received as 
intended from the mothers’ perspective (appendix).
The Structured Clinical Interview for DSM-IV-R for 
Axis  I disorders (SCID-IV-R) was done at baseline to 
establish the nature and duration of the mother’s 
depression, as well as comorbid disorders. If the mother 
was confirmed as eligible following the SCID-IV-R, she 
was invited to participate. The researcher also collected 
demographic information. The mother completed the 
Edinburgh Postnatal Depression Scale (EPDS) and the 
Infant Behaviour Questionnaire (IBQ).27 All diagnoses 
were reviewed by AS, and a Clinical Severity Rating (CSR) 
was assigned for major depressive disorder and each 
comorbid disorder (anxiety disorders, phobias, and eating 
disorders) from the information gathered during the 
SCID-IV-R.28 The CSR rating ranged from 0 to 8 and was 
used to characterise the severity of depression, with a 
score of 4 or 5 indicating moderately severe clinical 
depression and a score of 6 or more indicating severe 
depression. All assessment interviews were 
audio-recorded. From the IBQ scale of infant 
temperament, a score of reactivity was calculated. Children 
were categorised as difficult if they scored above the 
80th percentile.
A second assessment was done at the end of therapy 
when the infants were aged approximately 1 year. Data 
collected included the SCID, EPDS, and updates on 
maternal and child health.
Primary outcomes were obtained at the third 
assessment, when children were aged 2 years, an age at 
which developmental outcomes show stability and are 
relatively robust predictors of future development.29
At each assessment, mothers were given £20 for 
participation.
Outcomes
This randomised controlled trial had four primary 
outcomes: child cognitive development, language 
development, behaviour problems, and attachment 
security. Two primary outcomes (attachment security 
and behaviour problems) were assessed in the home; the 
other two were assessed in the Department of Psychiatry, 
University of Oxford, UK. Secondary outcomes were 
maternal depression, child emotion regulation, sustained 
attention, and emotion discrimination.
Child cognitive and language development were 
measured with the Bayley Scales of Infant and Toddler 
Development-Third Edition (BSID-III), a widely used 
and validated measure of functioning at 1–42 months.30 
The composite score, range 40–160, mean 100 (SD 15), 
has good reliability and stability31 and was used for each 
outcome. All assessments were video-recorded. 
Behaviour problems were assessed by maternal reports 
with the Child Behaviour Checklist (CBCL) questionnaire 
(for ages 1·5–5 years). This widely used measure has 
good discriminant validity and reliability.32 The principal 
outcome was the externalising scale (range 0–48). 
Attachment security was measured by the Attachment 
Q-Sort (AQS), comprising 90 items, designed to measure 
the security of a child’s attachment behaviour during a 
1·5 h naturalistic observation in the home. The measure 
is reliable, with good discriminant, convergent, and 
predictive validity.33 The 90 items were scored and sorted 
in order, from the “most characteristic” to the “least 
characteristic”, and a Pearson’s correlation was computed 
for each child with respect to security of attachment. 
Inter-observer reliability on AQS between trained 
observers (n=3) was computed on 22 families (16%), each 
visited by two observers simultaneously. Intra-class 
correlation coefficients ranged between 0·70 and 0·89.
Maternal depression was measured with the EPDS34 
and the SCID-CSR (completed at baseline, 1 year, and 
2 years following birth). For additional details, see the 
appendix. 
Child attention was assessed with the effortful control 
factor of the parent report early childhood behaviour 
questionnaire (ECBQ).35 Child emotion-regulation was 
assessed with the barrier paradigm from the Laboratory 
Temperament Assessment Battery (Lab-TAB).36 Emotion 
discrimination was assessed with a visual discrimination 
task with adult facial expressions of emotion as stimuli.37 
We originally intended to measure both child emotion 
regulation and child attention using more than one task 
each. However, because of the need to prioritise the 
primary outcome assessments, and the fact that children 
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sometimes became upset after completing the first 
emotion regulation task (the barrier paradigm), 
potentially affecting their performance in subsequent 
tests, we decided to use one test for each outcome only.
Parenting
Parenting was measured by observing mother–infant 
interactions at baseline, after treatment (child age 
approximately 1 year), and at the final assessment (child 
age 2 years). These assessments were done to examine 
whether there were differences between the groups and 
whether there were changes in parenting over time. We 
examined key parenting behaviours that are targeted by 
VFT: maternal following of child’s attention and 
contingent responsiveness; maternal warmth as a proxy 
for emotional scaffolding, comprising emotional and 
physical affection and support for the infant; and 
sensitivity and treating the child as a psychological agent 
(as evidenced by mind-mindedness). It was hypothesised 
that VFT would lead to greater improvements in these 
capacities, compared with PMR, and these effects would 
be mediated through to the child outcome.
Statistical analysis
The target number of participants was 144 (72 in each 
group). The sample size calculation was based on the 
Bayley Mental Development (MDI) Index by use of the 
Bayley Scales of Infant and Toddler Development-Second 
Edition (BSID-II). Cornish and colleagues38 report Bayley 
MDI scores for 15-month-old children according to 
maternal postnatal depression: no history, brief postnatal 
depression, and chronic postnatal depression. Based on 
an SD of 10·9, as reported for children of mothers with 
chronic postnatal depression, a sample size of 57 per 
group is necessary to detect a difference of 5·8 (as found 
by Cornish38) in the Bayley MDI scale, at the 5% significance 
level with 80% power. Allowing for 20% of participants to 
be lost to follow-up, a conservative estimate given the low 
attrition in our trials to date,8 72 participants per group 
were required. We used the BSID-III to measure the main 
outcome. This scale gives a score for cognitive and 
language development separately. With respect to the 
cognitive and language subscales available in the BSID-III, 
the proposed sample size had 80% power to detect a 
standardised treatment difference of 0·53. Piteo and 
colleagues39 subsequently reported BSID-III cognitive and 
language subscale scores at 18 months in 69 children of 
mothers with maternal depression in the first 6 months 
post partum. The SD was 11·9 for the cognitive subscale 
and 13·5 for the language subscale. Assuming these SDs 
for our trial, 57 participants per group had 80% power to 
detect a minimum difference of 6·3 in the cognitive scale 
and 7·2 in the language scale of BSID-III. There was no 
formal adjustment for multiple testing, since it would 
have severely over-corrected as the outcomes were 
associated.40 All primary outcomes were reported and 
interpreted together as specified in the primary hypothesis.
All outcome analyses were done according to the 
intention-to-treat principle. Missing data were 
assumed to be missing completely at random (MCAR). 
Departure from the MCAR assumption was considered 
in a separate sensitivity analysis of the primary 
outcomes. A pattern mixture model was applied to the 
data, allowing informative missing parameters to 
express the magnitude of departure from MCAR. The 
analysis for each primary outcome utilised an 
ANCOVA model with therapy group and the covariates 
of child sex, infant temperament, age of child (in 
months), socioeconomic status, and severity of 
postnatal depression (as assessed by the baseline 
SCID-CSR).
The SCID-CSR and EPDS were analysed by use of a 
linear mixed-effects model to account for repeated 
measurements on the same participant, including the 
same covariates as for the primary analysis, as well as a 
fixed effect for month of assessment (12 months and 
24 months) and interaction between month and 
treatment. This analysis allows us to estimate the 
difference between treatment groups at 1 year and 2 years 
after birth. The secondary outcomes of child emotion 
regulation, child attention, and emotion discrimination 
were analysed by means of an ANCOVA model in the 
same way as the primary outcomes. Parenting behaviours 
were compared between groups with Mann-Whitney 
U tests, and tests within treatment groups to measure 
changes from baseline were done with paired Wilcoxon 
signed rank tests.
Sensitivity analyses were done to assess the effect of 
compliance on the treatment difference by means of a 
complier average casual effect (CACE) analysis, to assess 
whether covariates predictive of missing data affected the 
treatment difference, and to assess whether including a 
therapist random effect changed the treatment difference. 
We tested for the moderation effects of antidepressant 
usage and presence of comorbid generalised anxiety 
disorder (GAD) and post-traumatic stress disorder 
(PTSD) at baseline, for the primary outcomes, by 
including an interaction term in the ANCOVA model 
between treatment group and the moderator variable. 
Each moderator was considered separately.
Analyses were done with Stata, version 13. All adverse 
and serious adverse events were reported to an 
independent data monitoring and ethics committee and 
to the research ethics committee.
This trial is registered with the ISRCTN registry, 
number ISRCTN07336477.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. AS, EN, LM, PJC, MGC, AN, and JM had full 
access to all the data in the study and AS, LM, and PJC 
had final responsibility for the decision to submit for 
publication.
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Results
The number of participants screened and randomised to 
receive either VFT or PMR is shown in the figure. 
Eligibility was assessed in 271 referrals, of whom 
31 declined to participate and 96 were ineligible: 
144 women were randomly assigned (n=72 in each 
group). Data on primary outcomes were available as 
follows: cognitive and language development (n=129); 
behaviour problems (n=132); and attachment security 
(n=132). Cognitive and language development were 
measured on average at age 25·6 months (SD 1·44), and 
behaviour problems and attachment security at age 
24·0 months (1·18). Secondary outcomes at 2 years were 
available for 131 participants on the SCID-CSR and the 
EPDS. For the child secondary outcomes, data were 
available for 123 children for emotion regulation, 131 for 
child attention, and 78 on the child emotion 
discrimination task. The figure also shows the number 
of participants who completed an adequate number of 
interventions (ie, completed at least nine sessions).
The main reasons for loss to follow-up were home 
circumstances (three participants in the VFT group, 
one in PMR) and not wishing to continue with the therapy 
(four participants in the VFT group, two in PMR). Other 
reasons included parent–child separation (one participant 
in the PMR group) and preferring to speak to a health 
visitor (one participant in the VFT group).
The demographic and clinical characteristics of the 
women are shown in table 1. The covariates used for 
minimisation and additional covariates (ethnicity, 
educational qualifications, previous counselling or 
psychotherapy, antidepressant usage, mother’s age, 
number of children living at home, and whether the 
child was living with the father) were generally well 
balanced between the two groups. Both groups had high 
rates of a history of previous depression, and moderately 
high rates of comorbid GAD. The number of participants 
taking antidepressant medication was 18 [25%] in the 
VFT group and 11 [15%] in the PMR group.
There was no evidence of treatment difference between 
the two groups for any of the primary outcomes: child 
cognitive development, language development, 
behaviour problems, or attachment security (table 2). 
There were missing data for the BSID-III for 
ten (13·9%) of 72 participants in the VFT group and 
five (6·9%) of 72 in the PMR group. The risk difference 
for missing data between the two therapies for cognitive 
and language development is 0·07 (95% CI –0·03 to 0·17). 
There were missing data for the CBCL and AQS security 
outcomes for eight (11·1%) participants in the VFT group 
and four (5·6%) in the PMR group. The risk difference 
for missing data between the two therapies for 
behavioural problems and for attachment security is 
0·06 (95% CI –0·03 to 0·15). The pattern mixture model 
showed no changes to the conclusions under the missing 
not at random assumption; sensitivity analyses including 
variables associated with missing data resulted in no 
changes to the conclusions. The CACE sensitivity 
analysis showed no significant treatment effect, although 
compliance was high for both therapies (130 [90·3%] of 
144 participants attended nine or more sessions; 
66 [91·7%] in the PMR group and 64 [88·9%] in the VFT 
group).
There were no significant moderation effects by 
antidepressant usage or by presence of comorbid GAD 
and PTSD at baseline for any of the primary outcomes 
(appendix).
At baseline, the mean depression score, as assessed by 
the EPDS, was 19·8 (SD 3·7) for the VFT group and 
19·4 (3·80) for the PMR group, which is indicative of 
127 excluded or declined to participate
     44 did not meet severity or chronicity criteria for depression
     31 no response, declined, or not interested
     31 infant age outside criteria
     7 receiving other therapy
    6 other psychiatric disorder
    3 infant low birthweight or gestational age <35 weeks 
    5 ineligible for other reasons 
Primary outcomes measured at 24 months:
68 with AQS
67 with BSID-III
68 with CBCL
68 analysed by AQS
67 analysed by BSID-III
68 analysed by CBCL
None excluded from analysis
72 allocated to control (PMR)
66 received 9 sessions or more
6 received 1–8 sessions
 Lost to follow-up (AQS, n=4;
      BSID-III, n=5; CBCL, n=4)
Did not like or want to
    continue with therapy
(AQS, n=2; BSID-III, n=2;
CBCL, n=2)
Unknown, complex home
    circumstances (AQS, n=2; 
    BSID-III, n=2; CBCL, n=2)
Did not complete assessment
    because of child refusal
    (BSID-III, n=1)
72 allocated to intervention (VFT)
64 received 9 sessions or more
8 received 1–8 sessions
Lost to follow-up (AQS, n=8;
      BSID-III, n=10; CBCL, n=8)
      Did not like or want to
     continue with therapy (AQS,
     n=4; BSID-III, n=4; CBCL, n=3)
Unknown, complex home
      circumstances (AQS, n=3;
      BSID-III, n=4; CBCL, n=3)
Did not complete assessment
    because of child refusal
    (BSID-III, n=1)
Preferred to talk to health
    visitor (AQS, n=1;  BSID-III,
    n=1; CBCL, n=1)
Questionnaire not returned
   (CBCL, n=1)
Primary outcomes measured at 24 months:
64 with AQS
62 with BSID-III
64 with CBCL
64 analysed by AQS
62 analysed by BSID-III
64 analysed by CBCL
None excluded from analysis
144 randomised
271 referrals
Figure: Trial profile
PMR=progressive muscle relaxation. VFT=video-feedback therapy. AQS=Attachment Q-Sort. BSID-III=Bayley Scales 
of Infant and Toddler Development-Third Edition. CBCL=Child Behaviour Checklist.
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severe depression (table 3). At the 2-year assessment, the 
mean depression score was 9·5 (SD 6·2) for the VFT 
group and 7·7 (4·5) for the PMR group. At both the 1-year 
and 2-year assessments, the EPDS scores for both 
treatment groups showed improvement, with significant 
changes from baseline within each group (p<0·0001) 
tested through a linear mixed-effects model. The results 
of the primary analysis, which assessed the mothers’ 
EPDS scores at 1-year and 2-year assessments, indicated 
no significant difference at 1 year (p=0·68), but a 
significant, albeit small, difference at 2 years, with the 
PMR group scoring significantly lower than the VFT 
group (table 3). The mean scores at both 1-year and 2-year 
assessments were well below the screening threshold for 
depression (≥13).
A linear mixed-effects model was used to account for 
the repeated measures of the SCID-CSR. Baseline 
SCID-CSR severity means were 5·3 (SD 0·7) for the VFT 
group and 5·4 (0·6) for the PMR group (table 3). At 
1 year, the mean SCID-CSR severity had decreased in 
both groups, and further decreased at 2 years, with 
significant decreases from baseline (p<0·0001) within 
each group; there were no significant differences 
between the groups (table 3). At 1 year, 55 (82·1%) of 
67 VFT participants and 57 (83·8%) of 68 PMR 
participants no longer met the criteria for major 
depressive disorder. By 2 years the remission rates 
increased slightly, with 56 (88·9%) of 63 VFT and 
58 (85·3%) of 68 PMR participants no longer meeting 
criteria for depression. 
There were no differences between the groups on the 
other secondary outcomes (tables 4 and 5).
Parenting behaviour did not differ significantly 
between treatment groups (tables 6, 7). Following 
child’s attention and contingent responsiveness 
improved in both groups from baseline to 1 year, and 
then again from 1 year to 2 years. Maternal warmth 
towards the child improved from baseline to 2 years in 
the VFT group but not in the PMR group. Sensitivity 
improved from baseline to 1 year and from baseline to 
2 years in both groups, but an ongoing improvement 
from 1 year to 2 years was observed only in the VFT 
group (table 6). There were no differences between 
baseline and 1 year in the mind-mindedness ratings in 
either group (table 7). Since there was no effect of 
treatment group on the outcomes, analysis examining 
whether parenting behaviours mediated child outcome 
was not relevant.
There were five serious adverse events in the VFT 
group (in two participants). There was one serious 
adverse event in the PMR group. There were six adverse 
events in the VFT group (in four participants). There 
were four adverse events in the PMR group (in 
four participants). None was treatment related. Since the 
numbers were very small, we have not provided a detailed 
breakdown to prevent possible identification of 
participants. Details are available from AS if required.
PMR (control); 
n=72
VFT (intervention); 
n=72
Mother’s age, years 32·2 (5·3) 31·7 (5·7)
Mother’s ethnicity
White British 58 (80·6%) 61 (84·7%)
Ethnicity other 14 (19·4%) 11 (15·3%)
Socioeconomic status
Manual 19 (26·4%) 19 (26·4%)
Non-manual 53 (73·6%) 53 (73·6%)
Mother’s educational qualifications
No qualifications 3 (4·2%) 1 (1·4%)
School level education 23 (31·9%) 32 (44·5%)
Certificate or diploma of 
higher education
9 (12·5%) 7 (9·7%)
University degree 37 (51·4%) 32 (44·5%)
Severity of postnatal depression
Severe 30 (41·7%) 30 (41·7%)
Moderately severe 42 (58·3%) 42 (58·3%)
Generalised anxiety disorder
Yes 19 (26·4%) 29 (40·3%)
No 53 (73·6%) 43 (59·7%)
Post-traumatic stress disorder
Yes 4 (5·6%) 6 (8·3%)
No 68 (94·4%) 66 (91·7%)
History of depression 
Yes: 1 episode 16 (22·2%) 27 (37·5%)
Yes: 2 or more episodes 30 (41·7%) 27 (37·5%)
No 26 (36·1%) 18 (25·0%)
Previous counselling or psychotherapy
Yes 45 (62·5%) 51 (70·8%)
No 27 (37·5%) 21 (29·2%)
Current antidepressant use
Yes 11 (15·3%) 18 (25·0%)
No 61 (84·7%) 54 (75·0%)
Infant’s age, months 6·8 (1·9) 6·8 (2·0)
<7 months 43 (59·7%) 41 (56·9%)
≥7 months 29 (40·3%) 31 (43·1%)
Infant sex
Male 37 (51·4%) 33 (45·8%)
Female 35 (48·6%) 39 (54·2%)
Infant temperament
Difficult 15 (20·8%) 16 (22·2%)
Not difficult 57 (79·2%) 56 (77·8%)
Number of children 1·6 (0·6) 1·7 (0·6)
1 34 (47·2%) 31 (43·1%)
2 35 (48·6%) 35 (48·6%)
3 or more 3 (4·2%) 6 (8·3%)
Living with father
Yes 64 (88·9%) 62 (86·1%)
No 8 (11·1%) 10 (13·9%)
Data are n (%) or mean (SD). PMR=progressive muscle relaxation. 
VFT=video-feedback therapy.
Table 1: Baseline demographic and clinical characteristics
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PMR (control) VFT (intervention) Treatment 
difference (95% CI)
p value
Cognitive development (BSID-III) n=67; 99·9 (12·9) n=62; 99·2 (12·0) –1·01 (–5·11 to 3·09) 0·63
Language development (BSID-III) n=67; 102·0 (16·3) n=62; 103·5 (17·2) 1·33 (–4·16 to 6·82) 0·63
Behaviour problems,  
externalising scale (CBCL)
n=68; 14·1 (7·2) n=64; 12·5 (8·8) –1·77 (–4·39 to 0·86) 0·19
Attachment security (AQS) n=68; 0·35 (0·25) n=64; 0·37 (0·20) 0·02 (–0·06 to 0·10) 0·58
Data are mean (SD) or adjusted treatment difference (95% CI). Linear mixed-effects model adjusting for infant age and 
sex, infant temperament, postnatal depression severity, and socioeconomic status. PMR=progressive muscle 
relaxation. VFT=video-feedback therapy. BSID-III=Bayley Scales of Infant and Toddler Development-Third Edition. 
CBCL=Child Behaviour Checklist. AQS=Attachment Q-Sort.
Table 2: Primary outcomes at child age 2 years
PMR (control) VFT 
(intervention)
Treatment 
difference 
(95% CI)
p value
EPDS
Baseline n=69; 19·4 (3·8) n=66; 19·8 (3·7) .. ..
1 year n=68; 9·3 (5·6) n=67; 9·5 (4·9) 0·37 
(–1·67 to 2·11)
0·68
2 years n=68; 7·7 (4·5) n=63; 9·5 (6·2) 1·93 
(0·17 to 3·70)
0·032
SCID-CSR
Baseline n=72; 5·4 (0·6) n=72; 5·3 (0·7) .. ..
1 year n=65; 2·3 (1·7) n=65; 2·4 (1·8) 0·11 
(–0·46 to 0·68)
0·71
2 years n=68; 1·8 (1·5) n=63; 2·1 (1·8) 0·31 
(–0·26 to 0·88)
0·29
Data are mean (SD) or treatment difference (95% CI). PMR=progressive muscle 
relaxation. VFT=video-feedback therapy. EPDS=Edinburgh Postnatal Depression 
Scale. SCID-CSR=Structured Clinical Interview for DSM IV Clinical Severity Rating.
Table 3: Secondary outcomes of maternal depression
Information on the data monitoring and ethics 
committee’s review of efficacy and safety data are reported 
in the appendix. Results on maternal perceptions of 
treatment are also reported in the appendix.
Discussion
Postnatal depression is associated with a range of 
negative child outcomes, especially when it is persistent, 
mediated by parenting difficulties associated with the 
disorder. Our randomised controlled trial targeted this 
high-risk group by recruiting mothers with persistent 
postnatal depression. In the context of providing all 
women with a psychological treatment for depression 
(CBT), we compared a treatment focusing on 
mother–child interactions (VFT) with an active control 
treatment (PMR). At 2 years of age, we observed no 
significant differences between groups on any of the 
child outcomes, with these outcomes being similar to the 
norms for non-clinical populations.30,33,41 Levels of 
maternal depression fell markedly across both groups by 
the end of treatment, with at least 80% of mothers no 
longer meeting diagnostic criteria. This improvement 
was sustained at 2 years post partum, with remission 
rates reaching 85%. There was a drop from baseline of 
almost 3 SD in depressive symptoms (EPDS) in both 
groups (with somewhat lower scores in the PMR group 
vs the VFT group). Thus, the majority of children were 
not exposed to maternal depression from the latter part 
of their first year through to the entire second year of life.
The key findings from this study are that, in a 
persistently depressed group of mothers who received an 
intensive home-based treatment, rates of remission were 
high and sustained and child development outcomes for 
both groups were close to the normative means.30,32,33,41 
These findings raise the possibility that treating maternal 
depression effectively and maintaining remission could 
be key to mitigating the longer-term negative effects of 
persistent postnatal depression on children.
Our findings raise two important questions. First, how 
were the high remission rates of maternal depression 
achieved? Second, given the commonly held view that 
providing treatment for the mother’s depression alone is 
insufficient to lead to improvements in child outcomes,17,18 
how should this study’s contrary findings be understood?
As noted by a US Preventive Services Taskforce paper 
in 2016, women with persistent and severe postnatal 
depression in the postnatal year have generally not been 
included in treatment studies, because of difficulties 
with recruitment and retention, as well as their complex 
therapeutic needs.42 Furthermore, most treatment studies 
have targeted postnatal depression in the early postnatal 
months, rather than depression that persists beyond the 
first 3 months. The absence of intervention research on 
persistent postnatal depression is a notable gap in the 
literature, given the strong evidence for its association 
with both maternal depression continuing in the longer 
term and negative effects on the child.6,43
Our finding of sustained remission is particularly 
striking since this was a sample of women with persistent 
postnatal depression and high levels of severity, making 
spontaneous remission unlikely. Indeed, in the only 
postnatal depression intervention study in mothers with 
depression of equivalent duration and severity to those of 
our study population, the remission rate following a 
course of interpersonal psychotherapy was only 37·5%.11
We believe there were four major contributors to the 
high rates of remission observed in the present study. 
PMR (control) VFT (intervention) Treatment difference (95% CI) p value
Barrier paradigm*
Child emotion regulation n=62; 2·0 (1·1) n=61; 1·7 (0·97) –0·32 (–0·70 to 0·07) 0·11
Attention*
Attentional focusing n=68; 4·3 (0·7) n=63; 4·4 (0·8) 0·04 (–0·22 to 0·31) 0·74
Attentional shifting n=68; 4·6 (0·6) n=63; 4·7 (0·6) 0·16 (–0·03 to 0·36) 0·10
Inhibitory control n=68; 4·0 (0·9) n=63; 4·1 (0·9) 0·07 (–0·24 to 0·38) 0·65
Data are mean (SD) or treatment difference (95% CI). PMR=progressive muscle relaxation. VFT=video-feedback 
therapy. *ANCOVA model adjusting for infant age and sex, infant temperament, postnatal depression severity, and 
socioeconomic status.
Table 4: Secondary outcomes at child age 2 years
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The first concerns the intensive nature of the treatment, 
with the majority of participants receiving almost all of 
the 11 treatment sessions. The second concerns the 
content of the CBT treatment, which was tailored to the 
postnatal period and focused on issues facing a mother 
with a young infant. Third, two booster sessions in the 
second year were included to reinforce the benefits of 
treatment and address relapse prevention. Boosters have 
been shown to be important in maintaining and 
enhancing positive treatment effects in primary care 
settings.44 Finally, the treatment was home-based. This 
was positively received, and many mothers said they felt 
more comfortable receiving help in their own homes 
than in a clinic.
The second issue to be addressed is that child outcomes 
did not appear to be compromised at 2 years in either of 
the two treatment groups, despite the fact that one of the 
groups did not directly address the mother–child 
relationship. Indeed, for both treatment groups, scores 
were similar to the norms of non-clinical populations on 
all child outcomes. This finding is at variance with the 
view that treating maternal depression alone is not 
sufficient to mitigate the effects of maternal depression 
on the child.9,17,18 However, some distinctive features of 
our study could have accounted for these results: the 
completion rate of treatments was high, and treatment 
was delivered over a prolonged period. Perhaps most 
notably, we found a marked and sustained improvement 
in maternal mood in both groups. This observation 
suggests that the favourable child outcome achieved in 
both groups was because the majority of children were 
not exposed to significant maternal depression from the 
end of their first year up to the age of 2 years. This view is 
consistent with evidence that children exposed to adverse 
caregiving environments that persist through their 
second year of life are particularly at risk of poor 
developmental outcomes, whereas those exposed only in 
their first year largely escape this risk.45 This explanation 
is likely because the second year is a period when several 
key developmental capacities (eg, language and emotion 
regulation) are becoming consolidated. Furthermore, 
PMR (control) VFT (intervention) Treatment difference 
(95% CI)*
p value
1 year n=65; 0·73 (0·47) n=65; 0·73 (0·45) –0·01 (–0·17 to 0·15) p=0·91
Change between 1 year 
and baseline
n=64; 0·14 (0·68) n=65; 0·09 (0·61) –0·07 (–0·30 to 0·16) p=0·53
Data are mean (SD) or treatment difference (95% CI). Outcomes are expressed as a proportion where the total count of 
appropriate mind-minded comments is divided by the maternal vocalisation rating score. PMR=progressive muscle 
relaxation. VFT=video-feedback therapy. *Linear regression model adjusting for infant age and sex, infant 
temperament, postnatal depression severity, and socioeconomic status. 
Table 7: Maternal parenting variable of mind-mindedness across treatment groups and change from 
baseline to 1 year
1 year Change between 1 year and baseline Change between 2 years and 1 year Change between 2 years and baseline
PMR (n=68) VFT (n=67) p value* PMR† (n=68) VFT† (n=67) p value* PMR† (n=68) VFT† (n=64) p value* PMR† (n=68) VFT† (n=63) p value*
Following 
child’s attention
4·00 
(3·42– 4·58)
4·00 
(3·33–4·00)
0·18 0·67 
(0·33–1·17) 
p<0·0001
0·67 
(0·00–1·17); 
p<0·0001
0·29 0·75 
(0·33 –1·67); 
p<0·0001
1·00 
(0·50–1·42); 
p<0·0001
0·14 1·5 
(1·08– 1·75); 
p<0·0001
1·42 
(1·13–1·96); 
p<0·0001
0·87
Contingent 
responsiveness
4·00 
(3·33– 4·33)
3·67 
(3·33–4·00)
0·46 0·33 
(0·00–1·00); 
p<0·0001
0·67 
(0·00–1·00); 
p<0·0001
0·80 0·79 
(0·21 –1·25); 
p<0·0001
0·83 
(0·50 –1·33); 
p<0·0001
0·48 1·33 
(0·96–1·67); 
p<0·0001
1·33 
(0·88–1·79); 
p<0·0001
0·79
Sensitivity 4·00 
(3·33– 4·33)
4·00 
(3·33–4·33)
0·45 0·33 
(0·00–1·00); 
p<0·0001
0·67 
(0·00–1·00); 
p<0·0001
0·81 –0·08 
(–0·33 to 0·42); 
p=0·37
0·17 
(–0·25 to 0·58); 
p=0·053
0·078 0·50 
(0·08–0·88); 
p<0·0001
0·71 
(0·21–1·25); 
p<0·0001
0·076
Warmth 4·00 
(3·42–4·33)
4·00 
(3·33–4·00)
0·43 0·00 
(–0·33 to 0·67); 
p=0·26
0·00 
(–0·67 to 0·33); 
p=0·67
0·098 –0·04 
(–0·50 to 0·33); 
p=0·30
0·17 
(–0·25 to 0·67); 
p=0·070
0·10 0·00 
(–0·33 to 0·54); 
p=1·00
0·21 
(–0·21 to 0·58); 
p=0·030
0·25
Data are median (IQR). PMR=progressive muscle relaxation. VFT=video-feedback therapy. *Mann-Whitney U test. †p value for paired Wilcoxon signed rank test. 
Table 6: Parenting variables across treatment groups and change from baseline to 2 years
Sad Neutral Happy
PMR (n=34) VFT (n=44) Treatment difference* PMR (n=34) VFT (n=44) Treatment difference* PMR (n=34) VFT (n=44) Treatment difference*
Eyes 1·32 (1·14) 0·98 (0·70) –0·34 (–0·74 to 0·06; p=0·10) 1·43 (1·20) 1·23 (0·89) –0·19 (–0·65 to 0·27; p=0·42) 1·15 (0·98) 0·94 (0·75) –0·15 (–0·52 to 0·23; p=0·43)
Face 3·44 (1·14) 3·47 (1·26) –0·62 (–0·41 to 0·64; p=0·66) 3·32 (1·14) 3·26 (1·24) 0·00 (–0·53 to 0·52; p=0·99) 3·42 (1·14) 3·36 (1·25) 0·03 (–0·50 to 0·56; p=0·91)
Face 
scene
3·51 (1·16) 3·54 (1·21) 0·13 (–0·39 to 0·65; p=0·62) 3·40 (1·18) 3·37 (1·18) 0·03 (–0·49 to 0·55; p=0·91) 3·51 (1·18) 3·46 (1·17) 0·07 (–0·44 to 0·58; p=0·79)
Mouth 1·05 (0·94) 1·07 (0·82) 0·07 (–0·32 to 0·46; p=0·72) 0·92 (1·01) 0·82 (0·72) –0·05 (–0·43 to 0·33; p=0·79) 1·04 (1·10) 1·03 (0·91) 0·02 (–0·43 to 0·47; p=0·92)
Data are mean (SD) or adjusted treatment difference (95% CI) on fixation duration to different facial features where faces are classified as sad, neutral, or happy. PMR=progressive muscle relaxation. 
VFT=video-feedback therapy. *Linear regression model adjusting for infant age and sex, infant temperament, postnatal depression severity, and socioeconomic status.
Table 5: Secondary outcome of emotion discrimination task at 2 years of age
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For more information about the 
MacBrain Face Stimulus Set 
contact Nim Tottenham at 
tott0006@tc.umn.edu
developmental outcomes at this stage show stability and 
are relatively robust predictors of future development.29
It is possible that VFT and PMR might each have had 
additional positive effects on child outcome, over and 
above the benefit to maternal depression, albeit through 
different mechanisms. VFT is a specific parenting 
intervention, whereas PMR might have influenced 
parenting indirectly by reducing stress, and thereby 
helping mothers respond to their infants.
A remaining issue is whether there are specific 
subgroups that might benefit from a parenting inter- 
vention in addition to treatment for depression. One 
important example is socioeconomic disadvantage, as 
observational studies have shown that the risk of adverse 
effects of postnatal depression on child outcomes is 
especially raised in this context. However, to our 
knowledge, no intervention study to date has targeted 
persistent postnatal depression in socioeconomically 
disadvantaged populations. Thus, it is difficult to 
speculate as to whether child outcomes might be 
different in this context, and therefore this is an 
important area for future research. An additional group 
of interest is women with comorbidities such as GAD 
and PTSD. In our sample, however, neither disorder, nor 
the use of antidepressants at baseline, moderated child 
outcomes.
A key strength of the present study is that the group 
studied was a high-risk sample of mothers recruited 
because of persistent depression that placed their 
children’s development at particular risk. There was high 
acceptability of treatments and low loss to follow-up. 
Home-based treatment meant that a high proportion of 
sessions were completed and there was low attrition, 
with 90% of participants judged to have received an 
adequate exposure to the intervention.
Limitations of the study included a relatively high 
education level of the sample as a whole; the CBCL being 
mother-rated, rather than being rated by an independent 
assessor; and the home-based setting of the treatment: it 
is not routine practice to have trained clinical 
psychologists provide intensive home-based treatment. 
However, given the need to provide effective treatments 
for mothers and infants at high risk46 and the acceptability 
and uptake of home-based treatments for women with a 
young infant, policies might need to incorporate this 
option. The fact that PMR is an effective treatment for 
anxiety is another limitation given the high rates of 
anxiety in both groups. Nonetheless, rates of remission 
from GAD did not differ between the groups (appendix) 
and baseline GAD did not moderate the outcome.
Recent research has emphasised the economic costs 
of perinatal mental illness, especially because of the 
effects on the child. Thus, addressing the needs of 
women with postnatal depression and their children is 
crucial and likely to yield important benefits to child 
development and to reduce costs to society. The results 
of this trial, done on a high-risk group of mothers with 
persistent postnatal depression, whereby risks to the 
child are especially elevated, suggest that if treatment 
for maternal depression successfully leads to remission, 
and the improvements in maternal mood are sustained, 
the adverse effects on children’s development can be 
largely mitigated. Our findings indicate that it is 
possible to achieve high rates of remission, even for 
persistent and severe postnatal depression, with 
intensive home-based psychological treatments tailored 
to the postnatal period. If these findings are replicated, 
they suggest that policy should focus on identifying 
women with persistent postnatal depression and 
providing them with accessible and effective treatment 
for their depression to both help the mothers and 
improve their children’s life chances.
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